BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to MDA-MB-436 cell line is 26
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALDH1A3 | 409 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | Irradiation | CFA followed by Western Blotting | NA | 0.28 | 0.0201 | 34708581 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | Irradiation | CFA followed by Western Blotting | NA | 0.28 | 0.5461 | 34708581 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | FACs for CSC marker followed by RT-PCR | NA | 0.28 | 0.5461 | 34235281 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5461 | 35326667 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5461 | 31337967 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | Irradiation | CFA followed by Western Blotting | NA | 0.28 | 0.6448 | 34708581 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | FACs for CSC marker followed by RT-PCR | NA | 0.28 | 0.6448 | 34235281 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.6448 | 35326667 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.6448 | 31337967 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | Irradiation | CFA followed by Western Blotting | NA | 0.28 | 0.5695 | 34708581 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5695 | 35326667 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | MACs and FACs | NA | 0.24 | 0.456 | 34235281 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | MACs and FACs | NA | 0.24 | 1 | 34235281 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | FACs | NA | 0.24 | 1 | 31729259 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | FACs followed by SFA | NA | 0.24 | 1 | 29249690 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | FACs followed by SFA | NA | 0.24 | 1 | 30479839 |
| BMI1 | 1066 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1135 | 31337967 |
| MYC | 7553 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1304 | 35326667 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | Irradiation | CFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 34708581 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | Docetaxel | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 28978427 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | Doxorubicin | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 28978427 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | Paclitaxel | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 28978427 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 31337967 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | FACs | NA | 0.12 | 0.456 | 31729259 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 29249690 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-436 | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 30479839 |